Skip to content
Browse

Edition

Sections

Appearance

AboutSourcesContactPrivacy

Experimental cholesterol drug fails to prevent heart attacks, strokes

First reported by NBC News Latest report 2 sources
Image: NPR
Image: NPR

Summary of 2 reports

An experimental drug that successfully lowered cholesterol levels failed to prevent heart attacks or strokes in clinical trials, contrary to researchers' expectations. Despite the drug's effectiveness at reducing this risk factor, the medication showed no measurable impact on patient outcomes.

Generated by AI using only the headlines and excerpts below. Read the original reporting for full details.

Read at NPR(opens in a new tab)

Full coverage

Every report we found on this story, oldest first. Each links to the original publisher.

  1. NBC News

    The ‘slam dunk’ that wasn’t: Promising cholesterol drug fails to prevent heart attacks or stroke (opens NBC News in a new tab)

    An experimental drug that held great promise in driving down a dangerous form of cholesterol didn’t show any measurable impact on heart attack or stroke in a clinical trial.

  2. NPR

    A promising new medicine against heart disease fails unexpectedly (opens NPR in a new tab)

    Doctors expected an experimental drug that lowers a common risk factor for heart attacks would save patients' lives. The medicine made no difference.

Something wrong with how we've grouped or summarised this story? Report a problem